Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: J Cardiopulm Rehabil Prev. 2020 Mar;40(2):108–115. doi: 10.1097/HCR.0000000000000446

Table 3.

Cardiopulmonary Exercise Test Outcomes

All Patients
N=128 (100%)
BAV/TAA
N=49 (38%)
TAV/TAA
N=51 (40%)
ATAAD
N=28 (22%)
P valuea
Weight, kg 90 (80,104) 93 (84,106) 89 (78,101) 85 (83,96) 0.17
Body mass index, kg.m−2 28.0 (26.2,31.6) 29.9 (26.3,33.6) 28.0 (26.0,31.3) 27.4 (26.3,29.9) 0.25
Resting, supine
 HR, bpm 65 (59,73) 67 (60,76) 64 (57,71) 63 (59,70) 0.21
 Systolic BP, mmHg 124 (116,138) 123 (116,132) 122 (112,134) 134 (120,145) 0.03c,d
 Diastolic BP, mmHg 77 (70,82) 77 (68,82) 76 (72,80) 77 (70,82) 0.92
Anaerobic Threshold (AT)
 VO2 at AT, mL.kg−1.min−1 13.1 (11.4,15.2) 13.6 (12.0,15.8) 13.0 (11.1,14.9) 13.1 (11.0,15.4) 0.44
 VE/VCO2 slope at ATe,f 25.9 (22.2,29.7) 24.4 (22.1,28.0) 27.4 (23.8,33.1) 23.7 (20.8,26.9) 0.03b,d
Peak
 HR, bpm 123 (108,142) 134(113,151) 118(107,142) 113(102,132) 0.01c
 % predicted, HR 77 (68,87) 81 (73,90) 77 (67,89) 71(64,77) 0.002c,d
 Systolic BP, mmHg 160 (144,172) 163 (151,175) 156 (140,170) 156 (140,180) 0.23
 Diastolic BP, mmHg 70 (62,80) 70 (62,80) 71 (64,80) 70 (62,80) 0.95
 VO2peak, mL.kg−1min−1 19.2 (15.9,22.9) 20.3 (16.2,24.0) 18.9 (15.9,22.5) 18.7 (16.1,20.4) 0.43
  Predicted VO2peak-FRIEND 29.5 (26.4, 34.8) 29.3 (27.3, 33.2) 27.8 (23.2, 30.9) 33.9 (27.7, 38.5) 0.008d
  % predicted, VO2peak-FRIEND 64 (55,76) 68 (57, 79) 67 (58, 83) 60 (47, 65) 0.006c,d
 Oxygen pulse 14.5 (12.0,16.6) 14.5 (12.8,17.0) 14.0 (11.9,16.6) 15.0 (11.9,16.5) 0.55
 VE/VCO2 slopef 28.3 (24.2,32.8) 26.6 (24.0, 30.5) 31.6 (27.2,34.5) 25.0 (22.9,31.4) 0.0008b,d
 METs 5.5 (4.5,6.5) 5.8 (4.6,6.8) 5.4 (4.5,6.4) 5.3 (4.6,5.8) 0.43
 Respiratory exchange ratio 1.16 (1.09,1.24) 1.19 (1.09,1.26) 1.17 (1.10,1.25) 1.12 (1.01,1.21) 0.07
 Exercise test duration, sec 600 (480,720) 606 (540,720) 600 (480,720) 540 (427,685) 0.13
Recovery
 1 min-HR, bpm 12 (7,16) 12(8,15) 10(7,15) 13(8,17) 0.37
 % abnormal, 1 min-HR 66 (52) 25 (51) 31 (63) 10 (36) 0.09
 Aortic insufficiency, mod-to-severe 2 (2) 0 1 (1.9) 1 (3.6) 0.23
 LVEF, % 50 (50,60) 50 (50,60) 50 (50,60) 60 (50,60) 0.03c

Data are reported as median (interquartile range) or n (%).

a

Overall p value,

b

BAV/TAA and TAV/TAA are significantly different,

c

BAV/TAA and ATAAD are significantly different,

d

TAV/TAA and ATAAD are significantly different

e

Slope from the start of exercise through AT

f

Slope was calculated using all exercise data (start through VO2peak)

Abbreviations: ATAAD, acute type A aortic dissection; BAV, bicuspid aortic valve; BP, bloods pressure; FRIEND, fitness registry and the importance of exercise national database; HR, heart rate; LVEF, left ventricular ejection fraction; MET, metabolic equivalent; TAA, thoracic aortic aneurysm; TAV, tricuspid aortic valve; VO2peak, peak oxygen consumption.